Product Information
RYVENT 6 MG TABLET is a brand (anda) product labeled by CarWin Pharmaceutical Associates LLC, priced at $8.1167 per EA under NDC 15370013010. Its NADAC has been published 374 times since Dec 19, 2018.
FDA first approved this application on May 31, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the carbinoxamine maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/1
Manufacturer
CarWin Pharmaceutical Associates LLCNDC
15370013010
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
CARBINOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA207484FDA Approved
5/31/2016
TE Code
AB
On Market Since
2/17/2017
Pharmacological Classes
Price Statistics
The NADAC for RYVENT 6 MG TABLET has been published 374 times since Dec 19, 2018, and over the history we have for it it has risen 94.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1167 per EA |
|---|---|
| All-time high | $8.1167 (Feb 11, 2026) |
| All-time low | $4.1660 (Dec 19, 2018) |
| 52-week high | $8.1167 |
| 52-week low | $8.1167 |
| Median price | $6.4075 |
| Average price | $6.3806 |
| Largest weekly change | +9.9% (Jan 22, 2020) |
| Weeks tracked | 374 |
| Tracking since | Dec 19, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+9.6%
5Y
+47.6%
All
+94.8%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the carbinoxamine maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RYVENT 6 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RYVENT 6 MG TABLET, manufactured by CarWin Pharmaceutical Associates LLC, is $8.1167 per EA (NDC 15370013010), effective Feb 11, 2026.
How has the price of RYVENT 6 MG TABLET changed over time?
Over the history we have for it, the NADAC for RYVENT 6 MG TABLET has risen 94.8%. It has been tracked across 374 weekly CMS publications since Dec 19, 2018.
What are the highest and lowest recorded NADAC prices for RYVENT 6 MG TABLET?
Since Dec 19, 2018, the NADAC for RYVENT 6 MG TABLET has ranged from a low of $4.1660 (Dec 19, 2018) to a high of $8.1167 (Feb 11, 2026), with a median of $6.4075 per EA.
Are there cheaper alternatives to RYVENT 6 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of RYVENT 6 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RYVENT 6 MG TABLET?
RYVENT 6 MG TABLET (NDC 15370013010) is labeled by CarWin Pharmaceutical Associates LLC, and CMS classifies it as a brand (anda) product.